Attorney Michel Brady Lynch, Esq. of The Michael Brady Lynch Firm in Winter Park spoke on March 11th in Ft. Lauderdale for Mass Torts Nexus on the subject Anticoagulant Uncontrollable Bleeding Litigation: Pradaxa, Xarelto and Eliquis. Mr. Lynch also spoke on March 16th in Orlando at the Ritz-Carlton Grande Lakes for HB Litigation Conferences: Mass Tort Med School on the topic Emerging Litigation: Eliquis Uncontrollable Bleeding Risks.
About Michael Brady Lynch
Michael Brady Lynch is the founder and lead trial attorney for The Michael Brady Lynch Firm. For over 20 years as a trial attorney, Michael has been a passionate consumer advocate for victims of defective drugs and their families. Michael Brady Lynch holds leadership positions in numerous State and Federal mass tort products liability actions, including:
- Plaintiff’s Steering Committee (“PSC”) of In re Pradaxa Products Liability Litigation MDL #2385, which resulted in a global settlement of claims in excess of $650 million.
- Plaintiff’s Executive Committee (PEC) in California coordinated Pradaxa litigation JCCP 4863, ongoing litigation representing victims of Pradaxa uncontrollable bleeding events post-MDL settlement.
- Plaintiff’s Leadership Committee (“PLC”) of In re Pradaxa Connecticut State Court Consolidated Proceeding, ongoing litigation representing victims of Pradaxa uncontrollable bleeding events post-MDL settlement.
- Plaintiff’s Steering Committee (“PSC”) of In re Viagra Products Liability Litigation MDL #2691, representing victims of melanoma associated with the erectile dysfunction drug Viagra.
- Bellwether Committee for In re Xarelto Products Liability Litigation MDL #2592, responsible for the analysis and selection of trial cases in the Xarelto MDL.
About The Michael Brady Lynch Firm
The Michael Brady Lynch Firm is a premier, national pharmaceutical and medical device trial firm concentrating on complex pharmaceutical and medical device mass tort litigation with offices in Winter Park, FL and Los Angeles, CA.